发明名称 Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure
摘要 Provided are methods of treating heart failure in children using B1-selective adrenergic receptor antagonists, alone or in combination with other agents, including B-2-selective adrenergic receptor agonists.
申请公布号 US9456997(B2) 申请公布日期 2016.10.04
申请号 US201113817969 申请日期 2011.08.25
申请人 THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 发明人 Stauffer Brian;Sucharov Carmen;Miyamoto Shelley
分类号 A61K31/137;A61K31/138;A61K31/352;A61K45/06;A61K31/165;A61K31/35 主分类号 A61K31/137
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A method of treating dilated cardiomyopathy in a pediatric subject comprising administering to said subject an effective amount of a β1-adrenergic receptor-selective antagonist, wherein said β1-adrenergic receptor-selective antagonist is at least twice as β1-selective as Metoprolol.
地址 Denver CO US